Successful liver transplantation from a donor with brodifacoum intoxication
β Scribed by Emre, Sukru ;Kitabayashi, Kazu ;Miller, Charles M.
- Publisher
- Wiley (John Wiley & Sons)
- Year
- 1999
- Tongue
- English
- Weight
- 43 KB
- Volume
- 5
- Category
- Article
- ISSN
- 1074-3022
No coin nor oath required. For personal study only.
β¦ Synopsis
We describe our use of a liver allograft from a donor who died of intracranial hemorrhage after brodifacoum ingestion. Because brodifacoum can remain in the human body for months, the recipient's posttransplantation coagulation profiles and serum brodifacoum levels were monitored closely. Her posttransplantation course was excellent, with no coagulation problem. At 15 months posttransplantation, she is well, with normal liver function and coagulation profile. We conclude that brodifacoum toxicity is not a strict contraindication to liver donation.
π SIMILAR VOLUMES
We report a successful living related liver transplantation from a donor with von Willebrand's disease. With proper preparation, a substantial liver resection can be performed safely in such patients, and the transplanted liver will function normally.
Pulmonary arterial hypertension (PAH) associated with portal hypertension [portopulmonary hypertension (PPHTN)] occurs in 2% to 10% of patients with advanced liver disease and carries a very poor prognosis without treatment. Most hepatic transplantation centers consider moderate to severe PPHTN to b
In Asia, various cultural, social, and historic factors have severely limited the availability of deceased donor organs. Therefore, living donor liver transplantation (LDLT) has emerged as an important therapeutic option for patients with end-stage liver disease. According to data reported to the Ko